Clinical Trial Detail

NCT ID NCT00854152
Title A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications

Advanced Solid Tumor

non-Hodgkin lymphoma

Therapies

GDC-0980

Age Groups: adult senior

No variant requirements are available.